| Literature DB >> 32292547 |
Xinglin Li1, Shanchao Wu2, Guoqiang Dong2, Shuqiang Chen2, Zonglin Ma1, Dan Liu1, Chunquan Sheng2.
Abstract
In order to improve the antitumor potency of the natural product evodiamine, novel boron-containing evodiamine derivatives were designed by incorporating boronic acid and boronate as trigger units. Boronate derivative 13a could be triggered by reactive oxygen species (ROS) in the HCT116 colon cancer cell line and showed excellent antitumor activity in vitro and in vivo. It induced apoptosis in HCT116 cancer cells in a dose-dependent manner and cell growth arrest at the G2 phase.Entities:
Year: 2020 PMID: 32292547 PMCID: PMC7153022 DOI: 10.1021/acsmedchemlett.9b00513
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345